Why X4 Pharmaceuticals Inc (NASDAQ: XFOR) Stock Should Not Be Taken For Granted By Investors In 2024
In the last trading session, 3.05 million shares of the X4 Pharmaceuticals Inc (NASDAQ:XFOR) were traded, and its beta was 0.49. Most recently the company’s